Raymond James & Associates Has $18.65 Million Position in John Wiley & Sons, Inc. (NYSE:WLY)

Raymond James & Associates cut its holdings in shares of John Wiley & Sons, Inc. (NYSE:WLY - Free Report) by 23.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 386,614 shares of the company's stock after selling 115,277 shares during the quarter. Raymond James & Associates owned 0.71% of John Wiley & Sons worth $18,654,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Cardinal Capital Management increased its stake in shares of John Wiley & Sons by 12.4% in the third quarter. Cardinal Capital Management now owns 33,307 shares of the company's stock worth $1,607,000 after acquiring an additional 3,679 shares during the last quarter. Wedge Capital Management L L P NC grew its position in John Wiley & Sons by 2.7% in the third quarter. Wedge Capital Management L L P NC now owns 31,297 shares of the company's stock worth $1,510,000 after acquiring an additional 830 shares in the last quarter. Code Waechter LLC acquired a new position in John Wiley & Sons during the third quarter worth $368,000. Contravisory Investment Management Inc. bought a new position in shares of John Wiley & Sons in the 3rd quarter valued at approximately $236,000. Finally, GAMMA Investing LLC raised its position in shares of John Wiley & Sons by 39.2% in the third quarter. GAMMA Investing LLC now owns 1,187 shares of the company's stock valued at $57,000 after purchasing an additional 334 shares during the period. Hedge funds and other institutional investors own 73.94% of the company's stock.

John Wiley & Sons Stock Performance

NYSE:WLY traded down $0.07 during midday trading on Friday, reaching $49.30. The stock had a trading volume of 195,986 shares, compared to its average volume of 345,709. The stock has a market capitalization of $2.68 billion, a P/E ratio of -13.54 and a beta of 0.86. The company has a debt-to-equity ratio of 1.27, a current ratio of 0.57 and a quick ratio of 0.53. John Wiley & Sons, Inc. has a 1-year low of $29.04 and a 1-year high of $51.79. The firm's fifty day simple moving average is $47.61 and its 200-day simple moving average is $43.24.

John Wiley & Sons (NYSE:WLY - Get Free Report) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.47 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.08). John Wiley & Sons had a positive return on equity of 21.59% and a negative net margin of 6.00%. The business had revenue of $403.81 million for the quarter, compared to analyst estimates of $387.40 million. During the same period in the prior year, the firm posted $0.27 EPS. John Wiley & Sons's revenue for the quarter was down 10.5% on a year-over-year basis.

John Wiley & Sons Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 24th. Stockholders of record on Tuesday, October 8th were issued a dividend of $0.352 per share. This represents a $1.41 annualized dividend and a dividend yield of 2.86%. The ex-dividend date of this dividend was Tuesday, October 8th. John Wiley & Sons's payout ratio is presently -38.74%.

Insiders Place Their Bets

In other John Wiley & Sons news, EVP Danielle Mcmahan sold 2,318 shares of John Wiley & Sons stock in a transaction that occurred on Tuesday, October 8th. The stock was sold at an average price of $49.41, for a total transaction of $114,532.38. Following the sale, the executive vice president now directly owns 8,978 shares of the company's stock, valued at approximately $443,602.98. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.79% of the company's stock.

John Wiley & Sons Profile

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.